Aquila Therapeutics

Leading the third wave of innovation in cell therapy beyond in vivo CAR-T

In vivo.  Single dose.  No lymphodepletion.

Creates a durable, combination cell therapy engineered to inflame and destroy solid tumors.

For more information: info@aquilatx.com